Verona Pharma PLC ADR

Quarterly Financials

Values in thousands 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Revenue
$5,624
$0
$0
$940
Gross Profit
5,081
-270
-262
730
EBITDA
-34,526
-53,243
-23,191
-14,003
EBIT
-34,792
-53,514
-23,454
-14,211
Net Income
-42,962
-70,914
-25,779
-14,254
Net Change In Cash
5,624
0
0
940
Free Cash Flow
-62,655
-16,784
-13,982
-10,420
Cash
336,040
404,598
254,882
271,772
Basic Shares
81,493
81,027
80,712
80,267

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$458
$458
$40,000
$2
Gross Profit
-679
112
40,000
-627
EBITDA
-52,467
-67,291
-42,189
-47,814
EBIT
-53,147
-67,927
-42,818
-48,442
Net Income
-54,369
-68,701
-55,569
-65,146
Net Change In Cash
458
458
40,000
2
Free Cash Flow
-50,222
-59,891
-33,266
-45,158
Cash
271,772
227,827
148,380
187,986
Basic Shares
79,267
66,133
59,148
32,866

Earnings Calls

Quarter EPS
2024-09-30
-$0.56
2024-06-30
-$0.88
2024-03-31
-$0.32
2023-12-31
-$0.18